Mr. Shane Madden reports

HYDREIGHT TECHNOLOGIES EXPANDS GLP-1 TELEHEALTH SUITE WITH LAUNCH OF LIRAGLUTIDE ON VSDHONE PLATFORM

Hydreight Technologies Inc. has expanded its VSDHOne platform with the launch of liraglutide. This addition marks a strategic expansion of Hydreight's growing GLP-1 weight management and wellness offerings, strengthening its commitment to accessible and innovative solutions through its national telehealth network.

Hydreight's current GLP-1 offerings now include:

• Semaglutide (weekly injectable);
• Tirzepatide (dual action, weekly injectable);
• Liraglutide (newly launched, daily injectable);
• Sublingual and buccal GLP-1s (needle-free administration).

These offerings include a range of delivery methods to meet the diverse needs of patients and providers -- from weekly or daily injectables to sublingual and buccal formats. Sublingual doses are dissolved under the tongue, and buccal is absorbed through the cheek, offering flexibility for those who prefer not to use needles while maintaining consistent dosage options. This variety ensures tailored, scalable solutions for weight management and metabolic care.

A strategic addition for stability and choice

As demand for GLP-1 medications surges, Hydreight's inclusion of liraglutide introduces a stable, patent-free and clinically proven option -- ideal for patients and providers seeking consistent long-term therapies amid evolving supply and regulatory landscapes. Unlike newer GLP-1 entrants, liraglutide's established record and daily dosing format offer flexibility without compromising efficacy.

"The launch of liraglutide further deepens our commitment to expanding access to proven GLP-1 therapies," said Shane Madden, chief executive officer of Hydreight. "It doesn't replace anything. It expands our offering. No matter how the landscape shifts, Hydreight users can count on a complete and reliable GLP-1 portfolio."

Why liraglutide?

Liraglutide is a GLP-1 receptor agonist used in the management of obesity and Type 2 diabetes. Delivered by a once-daily injection, it offers consistent and clinically proven efficacy. Compared with sublingual GLP-1s, which have lower bioavailability and shorter duration of action, liraglutide's injectable form ensures direct systemic absorption and predictable, long-lasting effects.

Comprehensive and customizable delivery options

Hydreight's GLP-1 portfolio now supports multiple delivery methods:

• Injectables: weekly, biweekly or daily based on patient needs;
• Sublingual: dissolved under the tongue;
• Buccal: absorbed through the inner cheek.

This mix of injectable, sublingual and buccal options positions Hydreight as a category leader in GLP-1 administration versatility. It allows medical professionals to provide customized, scalable care while ensuring patient adherence and comfort.

Unlocking access through VSDHOne

The VSDHOne platform enables a seamless patient journey -- from telehealth consultation to prescription and nationwide delivery. It supports medical professionals with flexible tools while ensuring regulatory compliance across all services.

"Hydreight isn't just a tech stack. We're a full-service medical infrastructure," added Mr. Madden. "With over 400 licences sold across the U.S., we're creating a scalable, future-ready solution for wellness, weight loss and personalized health care."

The addition of liraglutide and sublingual/buccal routes of administration for the GLP-1s reflects Hydreight's mission to expand access to premium wellness and weight management therapies through a convenient, compliant and nationwide telehealth network. The VSDHOne platform simplifies the entire patient journey from telehealth consult to prescription and delivery while offering medical professionals the flexibility to provide treatments at scale.

Liraglutide will be available to all eligible VSDHOne customers, ensuring widespread access to these innovative wellness treatments.

About Hydreight Technologies Inc.

Hydreight is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2,500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enables licensed health care professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, medspa technicians and other licensed health care professionals. The Hydreight platform allows health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

We seek Safe Harbor.